User profiles for Santabhanu Chakrabarti

Santabhanu Chakrabarti

Clinical Associate Professor, Department of Medicine , University of British Columbia
Verified email at mail.ubc.ca
Cited by 1257

Outcome of apparently unexplained cardiac arrest: results from investigation and follow-up of the prospective cardiac arrest survivors with preserved ejection fraction …

…, R Yee, R Leather, S Chakrabarti… - Circulation …, 2016 - Am Heart Assoc
Background— The Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)
enrolls patients with apparently unexplained cardiac arrest and no evident cardiac …

Balloon expandable stent implantation for native and recurrent coarctation of the aorta—prospective computed tomography assessment of stent integrity, aneurysm …

S Chakrabarti, D Kenny, G Morgan, SL Curtis… - Heart, 2010 - heart.bmj.com
Background Stenting for aortic coarctation is known to be effective in the medium term.
Aneurysm formation following stent implantation is a recognised complication. However, data …

Efficacy and safety of same-day discharge for atrial fibrillation ablation

…, P Khairy, R Zhang, L Ding, S Chakrabarti… - Clinical …, 2020 - jacc.org
Objectives The purpose of this study was to evaluate the efficacy, health care utilization, and
safety of a same-day discharge protocol. Background Catheter ablation of atrial fibrillation (…

[HTML][HTML] Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide …

…, T Moe, M Lipczyńska, SF Tsai, S Chakrabarti… - International journal of …, 2020 - Elsevier
Background Current guidelines consider vitamin K antagonists (VKA) the oral anticoagulant
agents of choice in adults with atrial arrhythmias (AA) and moderate or complex forms of …

[HTML][HTML] Bystanders are less willing to resuscitate out-of-hospital cardiac arrest victims during the COVID-19 pandemic

…, D Guh, KN Dainty, J Helmer, S Saini, A Chakrabarti… - Resuscitation …, 2020 - Elsevier
Aim The COVID-19 pandemic may influence the willingness of bystanders to engage in
resuscitation for out-of-hospital cardiac arrest. We sought to determine if and how the pandemic …

Comparison of ajmaline and procainamide provocation tests in the diagnosis of Brugada syndrome

…, M Gardner, JA Yeung-Lai-Wah, S Chakrabarti… - JACC: Clinical …, 2019 - jacc.org
Objectives : The authors studied the response rates and relative sensitivity of the most
common agents used in the sodium-channel blocker (SCB) challenge. Background : A type 1 …

Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)

…, S Sanatani, P Angaran, RM Gow, S Chakrabarti… - Heart rhythm, 2014 - Elsevier
Background Provocative testing with sodium channel blockers is advocated for the evaluation
of unexplained cardiac arrest (UCA) with the primary purpose of unmasking the typical …

Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia

…, M Talajic, K Ahmad, B Gerull, S Chakrabarti… - Heart Rhythm, 2014 - Elsevier
Background A systematic evaluation of patients with unexplained cardiac arrest (UCA) yields
a diagnosis in 50% of the cases. However, evolution of clinical phenotype, identification of …

Cardiac sarcoidosis

…, ACT Ha, LJ Gula, S Chakrabarti… - Clinics in chest …, 2015 - chestmed.theclinics.com
Studies have suggested that clinically manifest cardiac involvement occurs in perhaps 5%
of patients with pulmonary/systemic sarcoidosis. Clinical features of CS depend on the …

[HTML][HTML] Treatment and prevention of cardiovascular implantable electronic device (CIED) infections

P Phillips, AD Krahn, JG Andrade, S Chakrabarti… - CJC open, 2022 - Elsevier
An expanded role for cardiac implantable electronic devices (CIEDs) in recent decades
reflects an aging population and broader indications for devices, including both primary …